24/7 Market News Snapshot 19 August, 2025 – NovaBay Pharmaceuticals, Inc. (NYSE:NBY)

DENVER, Colo., 19 August, 2025 (www.247marketnews.com) – (NYSE:NBY) are discussed in this article.
NovaBay Pharmaceuticals, Inc. has experienced a momentous surge in its stock value, reflecting increased investor confidence and robust market performance. Following the opening price of $0.62, shares soared by over 60.86%, currently trading at $1.002, with a trading volume of 2.23 million shares. This dynamic activity in the biotech sector underscores a compelling opportunity for investors keen on innovative therapies.

In conjunction with this trading surge, NovaBay has announced a pivotal partnership through a $6 million securities purchase agreement with noted investor David E. Lazar. This deal includes the acquisition of non-voting convertible preferred stock, with an initial investment of $3.85 million already secured. Moreover, in a strategic realignment, Mr. Lazar is appointed as NovaBay’s Chief Executive Officer and joins the Board of Directors, while former CEO Justin Hall transitions to Vice President of Business Development.

This agreement follows the stockholders’ recent authorization to allow the Board to consider liquidation, thus enabling the company to pursue growth without resorting to dissolution. The strong backing from Mr. Lazar is expected to facilitate strategic opportunities that may enhance long-term value for shareholders, with Hall emphasizing the importance of Mr. Lazar’s expertise in capital restructuring to identify and capitalize on innovative business ventures.

Additionally, NovaBay plans to declare a special cash dividend to shareholders in the third quarter of 2025, further affirming its dedication to delivering shareholder returns. The completion of the investment’s second phase will depend on stockholder approval at the forthcoming annual meeting, illustrating a collaborative approach to steering the company’s future. This combination of strategic leadership and market momentum positions NovaBay for a transformative journey ahead.

Related news for (NBY)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.